The preventable burden of pneumococcal disease in the developing world

Vaccine

Volumn 25, Issue 13, 2007, Pages 2398-2405

  Scott, J A G ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Conjugate pneumococcal vaccine; Developing country; Incidence; Invasive pneumococcal disease

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; HUMAN; INCIDENCE; LOBAR PNEUMONIA; LOWER RESPIRATORY TRACT INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 33847668324     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.008     Document Type: Article

References (47)

1. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 14 (2003) 1341-1348
2. Cutts F.T., Zaman S.M.A., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in Gambia: randomized, double-blind, placebo-controlled trial. Lancet 365 9465 (2005) 1139-1146
3. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 18 (2003) 1737-1746
4. Kellner J.D., Church D.L., MacDonald J., Tyrrell G.J., and Scheifele D. Progress in the prevention of pneumococcal infection. CMAJ 173 10 (2005) 1149-1151
5. O'Dempsey T.J., McArdle T.F., Lloyd-Evans N., Baldeh I., Lawrence B.E., Secka O., et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 15 5 (1996) 431-437
6. Berkley J.A., Lowe B.S., Mwangi I., Williams T., Bauni E., Mwarubba S., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352 1 (2005) 39-47
7. Campbell J.D., Kotloff K.L., Sow S.O., Tapia M., Keita M.M., Keita T., et al. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J 23 7 (2004) 642-649
8. Brent A.J., Ahmed I., Ndiritu M., Lewa P., Ngetsa C., Lowe B., et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 367 9509 (2006) 482-488
9. Usen S., Adegbola R., Mulholland K., Jaffar S., Hilton S., Oparaugo A., et al. Epidemiology of invasive pneumococcal disease in the Western Region, Gambia. Pediatr Infect Dis J 17 1 (1998) 23-28
10. Arifeen SE, Saha SK, Rahman SM, Bari S, Naheed A, Mannan I, et al. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract PO3.32.
11. Batuwanthudawe BKR, Rajapakse LC, Abeysinghe MRN, Somaratne P, Dassanayaka M. Epidemiology of pneumococcal meningitis in children in the district of Colombo, Sri Lanka: a prospective, population based surveillance study. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract PO2.12.
12. Gray B.M., and Dillon H.C.J. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 5 2 (1986) 201-207
13. World Health Organization. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children (2001), Department of Vaccines and Biologicals, World Health Organization, Geneva
14. Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 83 5 (2005) 353-359
15. Magree H.C., Russell F.M., Sa'aga R., Greenwood P., Tikoduadua L., Pryor J., et al. Chest X-ray-confirmed pneumonia in children in Fiji. Bull World Health Organ 83 6 (2005) 427-433
16. Black S.B., Shinefield H.R., Ling S., Hansen J., Fireman B., Spring D., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia. Pediatr Infect Dis J 21 9 (2002) 810-815
17. United Nations Development Programme. Human development report: millennium development goals: a compact among nations to end human poverty. United Nations Development Programme (UNDP) (2003), Oxford University Press, New York p. 208-212
18. Sinha A, Levine O, Deloria Knoll M, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality. Lancet 2006, in press.
19. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., and Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2 1 (2002) 25-32
20. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54(36):893-897.
21. ARIVAC Consortium. Effectiveness of an 11-valent pneumococcal conjugate vaccine against pneumonia in Philippine children. 2000, http://hisdu2.sph.uq.edu.au/arivac/.
22. Ndiritu M, Nyiro J, Njenga S, Lewa P, Mwarumba S, Lowe BS, et al. Epidemiology of invasive pneumococcal disease among children in Kilifi District, Kenya. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract PO2.16.
23. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 366 9480 (2005) 144-150
24. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30 1 (2000) 100-121
25. Gordon S.B., Kanyanda S., Walsh A.L., Goddard K., Chaponda M., Atkinson V., et al. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 9 6 (2003) 747-749
26. Valles X., Flannery B., Roca A., Mandomando I., Sigauque B., Sanz S., et al. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health 11 3 (2006) 358-366
27. Hausdorff W.P. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 161 Suppl. 2 (2002) S135-S139
28. Madhi S.A., Kuwanda L., Cutland C., and Klugman K.P. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 40 10 (2005) 1511-1518
29. United States Census Bureau 2005. International Data Base. United States Department of Commerce, http://www.census.gov/ipc/www/idbnew.html, Washington DC, USA, accessed on March 27, 2006.
30. Riley I.D., Tarr P.I., Andrews M., Pfeiffer M., Howard R., Challands P., et al. Immunization with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1 8026 (1977) 1338-1341
31. Scott J.A., Hall A.J., Muyodi C., Lowe B., Ross M., Chohan B., et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 355 9211 (2000) 1225-1230
32. Fedson D.S., and Scott J.A.G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17 Suppl. 1 (1999) S11-S18
33. Schutze G.E., Tucker N.C., and Mason E.O.J. Impact of the conjugate pneumococcal vaccine in Arkansas. Pediatr Infect Dis J 23 12 (2004) 1125-1129
34. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Mitchel E., et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39 5 (2004) 641-648
35. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., and Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J 24 1 (2005) 17-23
36. Byington C.L., Samore M.H., Stoddard G.J., Barlow S., Daly J., Korgenski K., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41 1 (2005) 21-29
37. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 16 (2005) 2043-2051
38. Flannery B., Heffernan R.T., Harrison L.H., Ray S.M., Reingold A.L., Hadler J., et al. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 144 1 (2006) 1-9
39. Montgomery J.M., Lehmann D., Smith T., Mchael A., Hoseph B., Lupiwa T., et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua, New Guinea. Rev Infect Dis 12 Suppl. 8 (1990) S1006-S1016
40. Woolfson A., Huebner R., Wasas A., Chola S., Godfrey-Faussett P., and Klugman K. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Bull World Health Organ 75 5 (1997) 453-462
41. Lloyd-Evans N., O'Dempsey T.J., Baldeh I., Secka O., Demba E., Todd J.E., et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 15 10 (1996) 866-871
42. Hennessy TW, Singleton RJ, Bulkow L Cottle T, Harker-Jones M, Hurlburt D, et al. Increase in invasive pneumococcal disease in Alaska Native children due to serotypes not in the heptavalent pneumococcal conjugate vaccine, 2001-2005. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract SY2.06.
43. Levine O., O'Brien K.L., Knoll M., Adegbola R.A., Black S., Cherian T., et al. Pneumococcal vaccination in developing countries. Lancet 367 9526 (2006) 1880-1882
44. Thomas K, Steinhoff MC, Lalitha MK, Apama SS, Sharma P, Tulidar N, et al. Invasive pneumococcal disease in South Asia SAPNA network. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract SY3.03.
45. Saha SK, Naheed A, Arifeen SE, Islam M, Latif F, Amin MR, et al. Surveillance for invasive Streptococcus pneumoniae among children in Bangladesh: Antimicrobial susceptibility and serotype distribution. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract SY3.05.
46. Fischer JE, Peruski LF, Wongjindanon W, Jornrakate P, Kaewpan A, Sangsuk L, et al. Microbial surveillance for Streptococcus pneumoniae in rural Thailand: lessons learned, laboratory capacity, and the case for quality control. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract PO2.19.
47. Maranga WP, Mudhune S, Omolo L, Mhlanga B, Scott JAG, English M. The network for surveillance of pneumococcal disease in the East African region (Netspear): progress after 2 years. In: Proceedings of the Fifth International Symposium on pneumococci and pneumococcal diseases, Alice Springs, Australia, April 2-6, 2006. Abstract SY3.04.